Brokerages Set REGENXBIO Inc. (NASDAQ:RGNX) Target Price at $33.45
Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price target […]
Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average twelve-month price target […]
